Heartflow, Inc. Common Stock (HTFL) - Total Liabilities
Based on the latest financial reports, Heartflow, Inc. Common Stock (HTFL) has total liabilities worth $109.83 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore HTFL shareholders equity momentum to track the company's year-over-year net asset growth rate.
Heartflow, Inc. Common Stock - Total Liabilities Trend (2023–2024)
This chart illustrates how Heartflow, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data.
Heartflow, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Heartflow, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zibo Qixiang Tengda Chemical Co Ltd
SHE:002408
|
China | CN¥14.47 Billion |
|
Shanghai Zhenhua Heavy Industries Co Ltd A
SHG:600320
|
China | CN¥61.13 Billion |
|
ShenZhen Yitoa Intelligent Control Co Ltd
SHE:300131
|
China | CN¥1.95 Billion |
|
Establishment Labs Holdings Inc
NASDAQ:ESTA
|
USA | $336.25 Million |
|
Central China Securities Co Ltd
SHG:601375
|
China | CN¥42.83 Billion |
|
Olin Corporation
NYSE:OLN
|
USA | $5.40 Billion |
|
Jenoptik AG
F:JEN
|
Germany | €679.42 Million |
|
CETC Energy Joint Stock Co Ltd
SHG:600877
|
China | CN¥463.01 Million |
Liability Composition Analysis (2023–2024)
This chart breaks down Heartflow, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HTFL company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Heartflow, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Heartflow, Inc. Common Stock (2023–2024)
The table below shows the annual total liabilities of Heartflow, Inc. Common Stock from 2023 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $978.19 Million | +1.62% |
| 2023-12-31 | $962.62 Million | -- |
About Heartflow, Inc. Common Stock
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries… Read more